Abstract
- Population : Immunocompetent individuals living in JE-endemic areas
- Intervention: One dose of live recombinant JE vaccine
- Comparison: Placebo/no vaccination/other JE vaccine
- Outcome : Serious adverse events
GRADE table
AEFI
Japanese encephalitis
